Atea Pharmaceuticals (AVIR) Asset Utilization Ratio (2021 - 2022)

Atea Pharmaceuticals has reported Asset Utilization Ratio over the past 2 years, most recently at 0.28 for Q3 2022.

  • Quarterly results put Asset Utilization Ratio at 0.28 for Q3 2022, up 49.94% from a year ago — trailing twelve months through Sep 2022 was 0.28 (up 49.94% YoY), and the annual figure for FY2021 was 0.43, changed.
  • Asset Utilization Ratio for Q3 2022 was 0.28 at Atea Pharmaceuticals, down from 0.32 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for AVIR hit a ceiling of 0.43 in Q4 2021 and a floor of 0.08 in Q1 2021.